The snoRNAs (small nucleolar RNAs) comprise a large family of trans-acting RNAs that guide the modification (and in some cases cleavage) of ribosomal RNAs, small nuclear RNAs, and perhaps messenger RNAs. As such, the snoRNAs are essential for the production of spliceosomes and ribosomes - the mRNA splicing and protein translation machinery of the cell. A deficiency in the expression of some snoRNAs has been linked with the neurogenetic disease Prader-Willi Syndrome, and deletion of other snoRNAs is lethal. The goal of this project is to determine how the snoRNAs assemble with proteins into functional complexes (snoRNPs) and are transported within the cell. We will employ a combination of biochemical, cytological, and genetic approaches and will exploit two systems (Xenopus laevis oocytes and Saccharomyces cerevisiae) for in vivo studies. We will investigate the organization of core snoRNP proteins on each of two functional classes of snoRNPs in vivo, establishing a necessary framework for understanding the assembly and function of snoRNPs. In addition, we will investigate the roles of accessory proteins in the assembly and transport of snoRNPs. One protein that we will focus on, SMN, is linked to spinal muscular atrophy, a fatal recessive genetic disease with an incidence of approximately 1 in 10,000 human births. Our work will investigate the normal cellular functions of SMN and other proteins. Finally, we will characterize gene products identified in directed genetic screens in order to understand their roles in snoRNP biogenesis and intracellular trafficking. The insight that we gain into the mechanisms by which RNAs are transported will provide a foundation for understanding the trafficking of all RNAs that pass through the nucleus and for rational targeting of RNA-based therapeutic agents being developed to treat a wide range of human infections and diseases. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
3R01GM054682-08S1
Application #
7035472
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Rhoades, Marcus M
Project Start
1997-08-01
Project End
2007-03-31
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
8
Fiscal Year
2005
Total Cost
$110,400
Indirect Cost
Name
University of Georgia
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
004315578
City
Athens
State
GA
Country
United States
Zip Code
30602
Elmore, Joshua R; Sheppard, Nolan F; Ramia, Nancy et al. (2016) Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR-Cas system. Genes Dev 30:447-59
Sheppard, Nolan F; Glover 3rd, Claiborne V C; Terns, Rebecca M et al. (2016) The CRISPR-associated Csx1 protein of Pyrococcus furiosus is an adenosine-specific endoribonuclease. RNA 22:216-24
Swarts, Daan C; Hegge, Jorrit W; Hinojo, Ismael et al. (2015) Argonaute of the archaeon Pyrococcus furiosus is a DNA-guided nuclease that targets cognate DNA. Nucleic Acids Res 43:5120-9
Elmore, Joshua; Deighan, Trace; Westpheling, Jan et al. (2015) DNA targeting by the type I-G and type I-A CRISPR-Cas systems of Pyrococcus furiosus. Nucleic Acids Res 43:10353-63
Majumdar, Sonali; Zhao, Peng; Pfister, Neil T et al. (2015) Three CRISPR-Cas immune effector complexes coexist in Pyrococcus furiosus. RNA 21:1147-58
Makarova, Kira S; Wolf, Yuri I; Alkhnbashi, Omer S et al. (2015) An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol 13:722-36
Hale, Caryn R; Cocozaki, Alexis; Li, Hong et al. (2014) Target RNA capture and cleavage by the Cmr type III-B CRISPR-Cas effector complex. Genes Dev 28:2432-43
Terns, Rebecca M; Terns, Michael P (2014) CRISPR-based technologies: prokaryotic defense weapons repurposed. Trends Genet 30:111-8
Ramia, Nancy F; Spilman, Michael; Tang, Li et al. (2014) Essential structural and functional roles of the Cmr4 subunit in RNA cleavage by the Cmr CRISPR-Cas complex. Cell Rep 9:1610-1617
Shao, Yaming; Cocozaki, Alexis I; Ramia, Nancy F et al. (2013) Structure of the Cmr2-Cmr3 subcomplex of the Cmr RNA silencing complex. Structure 21:376-84

Showing the most recent 10 out of 41 publications